Functional MR Imaging versus Wada Test for Evaluation of Language Lateralization: Cost Analysis

Radiology

Volumn 230, Issue 1, 2004, Pages 49-54

  Medina, L Santiago ^a   Aguirre, Elsa ^a   Bernal, Byron ^a   Altman, Nolan R ^a  

^a MIAMI CHILDREN'S HOSPITAL   (United States)

Author keywords

Brain, function; Cost effectiveness; Electroencephalography (EEG); Magnetic resonance (MR), functional imaging

Indexed keywords

ACCOUNTING; ADULT; ARTICLE; CALCULATION; CLINICAL ARTICLE; COST BENEFIT ANALYSIS; FEMALE; HEMISPHERIC DOMINANCE; HUMAN; IMAGING SYSTEM; LANGUAGE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERSONNEL; PRIORITY JOURNAL; REIMBURSEMENT; STUDENT T TEST; WADA TEST;

ADULT; BRAIN; COSTS AND COST ANALYSIS; ELECTROENCEPHALOGRAPHY; FEMALE; FUNCTIONAL LATERALITY; HUMANS; LANGUAGE; MAGNETIC RESONANCE IMAGING; MALE; PROSPECTIVE STUDIES;

EID: 0348109339     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2301021122     Document Type: Article

References (40)

1. Lurito JT, Bryan RN, Vincent PM, Ulmer JL, Lowe MJ. Functional brain mapping. In: Smirniotopoulos JG, ed. 2000 syllabus: categorical course in diagnostic radiology-neuroradiology. Oak Brook, Ill: Radiological Society of North America, 2000; 79-104.
2. Schlosser MJ, Luby M, Spencer DD, Awad IA, McCarthy G. Comparative localization of auditory comprehension by using functional magnetic resonance imaging and cortical stimulation. J Neurosurg 1999; 91:626-635.
3. Hertz-Pannier L, Gaillard W, Mott S. Noninvasive assessment of language dominance in children and adolescents with functional MRI: a preliminary study. Neurology 1997; 48:1003-1102.
4. Benson RR, Fitzgerald DB, LeSueur LL, et al. Language dominance determined by whole brain functional MRI in patients with brain lesions. Neurology 1999; 52:798-809.
5. Desmond JE, Sum JM, Wagner AD, et al. Functional MRI measurement of language lateralization in Wada tested patients. Brain 1995; 118:1411-1419.
6. Binder JR, Swanson SJ, Hammeke TA, et al. Determination of language dominance using functional MRI: a comparison with the Wada test. Neurology 1996; 46:978-984.
7. Worthington C, Vincent DJ, Bryant AE, et al. Comparison of functional magnetic resonance imaging for language localization and intracarotid speech amytal testing in presurgical evaluation for intractable epilepsy: preliminary results. Stereotact Funct Neurosurg 1997; 69:197-201.
8. Bahn MM, Lin W, Silbergeld DL, et al. Localization of language cortices by functional MR imaging compared with intracarotid amobarbital hemispheric sedation. AJR Am J Roentgenol 1997; 169:575-579.
9. Yetkin FZ, Swanson S, Fischer M, et al. Functional MR of frontal lobe activation: comparison with Wada language results. AJNR Am J Neuroradiol 1998; 19:1095-1098.
10. Bazin B, Cohen L, Lehericy S, et al. Study of hemispheric lateralization of language regions by functional MRI: validation with the Wada test. Rev Neurol Paris 2000; 15:145-148. [French]
11. Gold MR, Siegel SE, Russell LB, Weinstein MC, eds. Cost-effectiveness in health and medicine. New York, NY: Oxford University Press, 1996; 193-194.
12. Baumol WJ, Blinder AS. Production, inputs, and costs: building blocks for supply analysis. In: Baumol WJ, Blinder AS, eds. Microeconomics: principles and policy. 7th ed. Fort Worth, Tex: Dryden, 1997; 147-179.
13. Strauss E, Wada J. Hand preference and proficiency and cerebral speech dominance determined by the carotid amytal test. J Clin Exp Neuropsychol 1988; 10:169-174.
14. Oxbury SM, Oxbury JM. Intracarotid amytal test in the assessment of language dominance. Adv Neurol 1984; 42:115-123.
15. Rubin GD, Armerding MD, Dake MD, Napel SN. Cost identification of abdominal aortic aneurysm imaging by using time and motion analyses. Radiology 2000; 215:63-70.
16. American Hospital Association. Estimated useful lives of depreciable hospital assets. Chicago, Ill: American Hospital Publishing, 1998.
17. Bell RA. Economics of MRI technology. J Magn Reson Imaging 1996; 6:10-25.
18. Hennekens CH, Buring JE. Epidemiology in medicine. Boston, Mass: Little, Brown, 1987; 252-258.
19. Rosner B. Fundamentals of biostatistics. 4th ed. Belmont, Calif: Duxbury, 1995; 141-190.
20. Glantz SA. Primer of biostatistics. 2nd ed. New York, NY: McGraw-Hill, 1987; 163-190.
21. Blackmore CC, Magid DJ. Methodologic evaluation of the radiology cost-effectiveness literature. Radiology 1997; 203:87-91.
22. Eisenberg JM. Clinical economics: a guide to the economic analysis of clinical practices. JAMA 1989; 262:2879-2886.
23. Weinstein MC, Statson WB. Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med 1977; 296: 716-721.
24. Silverman SG, Dueson TE, Kane N, et al. Percutaneous abdominal biopsy: cost-identification analysis. Radiology 1998; 206:429-435.
25. Remar EM, Herts BR, Streem SB, et al. Spiral noncontrast CT versus combined plain radiography and renal US after extra-corporeal shock wave lithotripsy: cost-identification analysis. Radiology 1997; 204:33-37.
26. van Erkel AR, van Rossum AB, Bloem JL, Kievit J, Pattynama PM. Spiral CT angiography for suspected pulmonary embolism: a cost-effectiveness analysis. Radiology 1996; 201:29-36.
27. Vanninen R, Manninen H, Soimakallio S. Imaging of carotid artery stenosis: clinical efficacy and cost-effectiveness. AJNR Am J Neuroradiol 1995; 16:1875-1883.
28. Picus D. Comparing competing medical procedures: cost or charges-what should it matter? Radiology 1996; 199:623-625.
29. Finkler SA. The distinction between cost and charges. Ann Intern Med 1982; 96:102-109.
30. Russi TJ, Libby DM, Henschke CI. Clinical utility of computed tomography in the diagnosis of pulmonary embolism. Clin Imaging 1997; 21:175-182.
31. Rubens DJ, Strang JG, Fultz PJ, Gottlieb RH. Sonographic guidance of mediastinal biopsy: an effective alternative to CT guidance. AJR Am J Roentgenol 1997; 169:1605-1610.
32. Dwamena BA, Kloos RT, Fendrick AM, et al. Diagnostic evaluation of the adrenal incidentaloma: a decision and cost-effectiveness analyses. J Nucl Med 1998; 39:707-712.
33. Yin D, Forman HP. Health care cost-benefit and cost-effectiveness: an overview. J Vasc Interv Radiol 1995; 6:311-320.
34. Shwartz M, Young DW, Siegrist R. The ratio of costs to charges: how good a basis for estimating costs? Inquiry 1995; 32:476-481.
35. Topol EJ, Leya F, Pinkerton CA, et al. A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease: the CAVEAT Study Group. N Engl J Med 1993; 329:221-227.
36. Guzman LA, Simpfendorfer C, Fix J, Franco I, Whitlow PL. Comparison of costs of new atherectomy devices and balloon angioplasty for coronary artery disease. Am J Cardiol 1994; 74:22-25.
37. Hunink MG, Cullen KA, Donaldson MC. Hospital costs of revascularization procedures for femoropopliteal arterial disease. J Vasc Surg 1994; 19:632-641.
38. Brasel KJ, Weigelt JA. Blunt thoracic aortic trauma: a cost-utility approach for injury detection. Arch Surg 1996; 131:619-626.
39. Yin D, Baum RA, Carpenter JP, Langlotz CP, Pentecost MJ. Cost-effectiveness of MR angiography in cases of limb-threatening peripheral vascular disease. Radiology 1995; 194:757-764.
40. Hunink MG, Bos JJ. Triage of patients to angiography for detection of aortic rupture after blunt chest trauma: cost-effectiveness analysis of using CT. AJR Am J Roentgenol 1995; 165:27-36.